Jane Street’s Molecular Partners MOLN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-16,816
Closed -$102K 9103
2023
Q2
$102K Hold
16,816
﹤0.01% 7994
2023
Q1
$99.8K Sell
16,816
-157
-0.9% -$1.01K ﹤0.01% 8229
2022
Q4
$111K Sell
16,973
-6,745
-28% -$43.8K ﹤0.01% 8035
2022
Q3
$159K Sell
23,718
-3,326
-12% -$21.2K ﹤0.01% 8357
2022
Q2
$183K Sell
27,044
-2,114
-7% -$21.8K ﹤0.01% 8257
2022
Q1
$591K Sell
29,158
-1,812
-6% -$44K ﹤0.01% 7155
2021
Q4
$594K Buy
+30,970
New +$521K ﹤0.01% 6936

Other funds holding MOLN

Jane Street's MOLN Position: Q3 2023 in Review

Jane Street sold out of Molecular Partners (MOLN) in Q3 2023, closing a stake of 16,816 shares — an estimated $102K sold.

Jane Street first reported a position in MOLN in Q4 2021 and held it in 7 quarters. The position peaked at $594K in Q4 2021. 7 funds tracked by Wall St. Rank hold MOLN as of Q3 2023.

  • Jane Street reported no remaining Molecular Partners position as of Q3 2023 after selling out during the quarter.
  • Jane Street sold 16,816 Molecular Partners shares in Q3 2023, an estimated $102K.
  • Jane Street first reported a position in Molecular Partners in Q4 2021 and held it in 7 quarters.
  • Jane Street's Molecular Partners position peaked at $594K in Q4 2021.
  • 7 funds tracked by Wall St. Rank held Molecular Partners as of Q3 2023.

Based on Jane Street's 13F filing for Q3 2023, filed 15 Nov 2023.